Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


April 26, 2015 6:39 PM ET

Healthcare Providers and Services

Company Overview of NeoGenomics Laboratories, Inc.

Company Overview

NeoGenomics Laboratories, Inc. provides cancer genetic diagnostic testing services to pathologists, oncologists, urologists, other clinicians, reference laboratories, and hospitals in the United States. Its testing services include cytogenetic, fluorescence in-situ hybridization, flow cytometry, morphology studies, immunohistochemistry, anatomic pathology, and molecular genetic testing services. NeoGenomics also offers a Web-based laboratory reporting application; laboratory information system/electronic medical records integration solutions; and tech-only services. The company was founded in 2001 and is based in Fort Myers, Florida with labs in Nashville, Tennessee; Irvine, California; and ...

12701 Commonwealth Drive

Suite 9

Fort Myers, FL 33913

United States

Founded in 2001

Phone:

239-768-0600

Fax:

239-690-4237

Key Executives for NeoGenomics Laboratories, Inc.

Executive Chairman and Chief Executive Officer
Age: 59
Founder and Director
Age: 49
Chief Financial Officer
Age: 52
Chief Operating Officer
Age: 43
Principal Accounting Officer and Director of Finance
Compensation as of Fiscal Year 2014.

NeoGenomics Laboratories, Inc. Key Developments

NeoGenomics Laboratories, Inc. and Path Labs, LLC Announces Amended and Restated Revolving Credit and Security Agreement

On August 26, 2014, that certain Amended and Restated Revolving Credit and Security Agreement, dated April 26, 2010 (as amended, the Credit Agreement), by and between NeoGenomics Laboratories, Inc., Path Labs, LLC (Path Labs), NeoGenomics, Inc. (the Registrant, and collectively with NeoGenomics Laboratories, Inc. and Path Labs, the Company) and CapitalSource Finance, LLC was terminated at the option of the company. The Credit Agreement set forth the terms of a credit facility whereby NeoGenomics Laboratories, Inc. and Path Labs were borrowers and the company served as guarantor thereunder. All amounts owed by the company under such credit facility were paid in full prior to the termination of the Credit Agreement.

Similar Private Companies By Industry

Company Name Region
Radiology & Diagnostic Imaging, PSC United States
Columbia/HCA John Randolph, Inc. United States
Garfield Medical Center Inc. United States
National Healthcare of Leesville, Inc. United States
The Park at Trowbridge United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NeoGenomics Laboratories, Inc., please visit www.neogenomics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.